BridgeBio Pharma, Bayer agree on licensing deal for heart disease drug in Europe, ET HealthWorldby India News Online Team March 4, 2024 0 London: BridgeBio Pharma has granted German drugmaker Bayer an exclusive license to commercialise its heart disease drug in Europe, the companies said on Monday.The experimental drug, acoramidis, is being ...